CHICAGO--(BUSINESS WIRE)--Monroe Capital LLC (“Monroe”) announced it acted as joint lead arranger on the funding of a senior credit facility to support the acquisition of Voyce Global (“Voyce”) by ...

Company to showcase its Multi Kinase Inhibitor (MKI) platform and late-stage clinical programs in pterygium and ...

A monthly overview of things you need to know as an architect or aspiring architect. Unlock the full InfoQ experience by logging in! Stay updated with your favorite authors and topics, engage with ...

IRVINE, Calif., April 09, 2026 (GLOBE NEWSWIRE)-- Cloudbreak Pharma Inc., (HKEX 2592), a clinical stage ophthalmic drug company leveraging its proprietary Multi Kinase Inhibitor (MKI) discovery ...

Cloudbreak Pharma is targeting pterygium, an ocular disease also known as “surfer’s eye,” caused by exposure to high levels of ultraviolet radiation. Pterygium is a growth of fleshy tissue extending ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. There were times when, to make payroll, Andy Panos didn't ...

Cloudbreak, an interpreter service for the medical industry received $10 million in funding from Columbia Partners Private Capital of Bethesda, Md. Cloudbreak has new funding for more services.

View post: This Genius Diaper Bag Fits Everything You Need for Travel. It's the Best I Reviewed for Men's Journal's Travel Awards Breaking Down Cloudbreak Ian Walsh, Shane Dorian, and Dave Wassel ...